Certified by Founder Lodge
Beacon Therapeutics
United States - Alachua, Florida
START UP
1 Disclosed Funding Rounds $170,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindne
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 10 ,2024 | Series B | $170,000,000 |
Oxford Science Enterprises
Advent Life Sciences
Forbion
Syncona Limited
University of Oxford
TCGX
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
